These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18084182)

  • 21. Footdrop, foot rotation, and plantarflexor failure in Charcot-Marie-Tooth disease.
    Vinci P; Perelli SL
    Arch Phys Med Rehabil; 2002 Apr; 83(4):513-6. PubMed ID: 11932853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease.
    Kuruvilla A; Costa JL; Wright RB; Yoder DM; Andriacchi TP
    Neurol India; 2000 Mar; 48(1):49-55. PubMed ID: 10751814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of foot and ankle strength training in childhood Charcot-Marie-Tooth disease.
    Burns J; Raymond J; Ouvrier R
    Neuromuscul Disord; 2009 Dec; 19(12):818-21. PubMed ID: 19819697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast responses to stepping on an unexpected surface height depend on intact large-diameter nerve fibers: a study on Charcot-Marie-Tooth type 1A disease.
    van der Linden MH; de Kam D; van Engelen BG; Hendricks HT; Duysens J
    J Neurophysiol; 2009 Sep; 102(3):1684-98. PubMed ID: 19625532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tendon transfers for peroneal palsy - functional outcome].
    Kremer T; Riedel K; Germann G; Heitmann C; Sauerbier M
    Handchir Mikrochir Plast Chir; 2011 Apr; 43(2):95-101. PubMed ID: 21509700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pes cavus pathogenesis in Charcot-Marie-Tooth disease type 1A.
    Burns J; Ouvrier R
    Brain; 2006 Jul; 129(Pt 7):E50; author reply E51. PubMed ID: 16803835
    [No Abstract]   [Full Text] [Related]  

  • 27. [A comparative evaluation of the efficacy of physical treatment methods in Charcot-Marie-Tooth neural amyotrophy].
    Lobzin VS; Saĭkova LA; Shiman AG; Kosachev VD
    Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (6):53-6. PubMed ID: 2077741
    [No Abstract]   [Full Text] [Related]  

  • 28. [Visual, auditory and somatosensory pathway involvement in Charcot-Marie-Tooth disease].
    Tang XF; Werner T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):357-62. PubMed ID: 6241088
    [No Abstract]   [Full Text] [Related]  

  • 29. Poor compliance with ankle-foot-orthoses in Charcot-Marie-Tooth disease.
    Vinci P; Gargiulo P
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):27-31. PubMed ID: 18385625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of stock orthoses to assist gait in neuromuscular disorders: a pilot study.
    Farmer SE; Pearce G; Whittall J; Quinlivan RC; Patrick JH
    Prosthet Orthot Int; 2006 Aug; 30(2):145-54. PubMed ID: 16990225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of kineceptive loss in CMT with an elastic ankle support.
    Siegel IM
    Muscle Nerve; 1994 Jul; 17(7):827. PubMed ID: 8008016
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral neuropathy: the importance of history and examination for correct diagnosis.
    Kelly JJ
    Rev Neurol Dis; 2005; 2(3):150-3. PubMed ID: 16400316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthopaedic shoes improve gait in a Charcot-Marie-Tooth patient: a combined clinical and quantified case study.
    Guzian MC; Bensoussan L; Viton JM; Mihle de Bovis V; Ramon J; Azulay JP; Delarque A
    Prosthet Orthot Int; 2006 Apr; 30(1):87-96. PubMed ID: 16739785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gait analysis in patients with Parkinson's disease off dopaminergic therapy.
    Svehlík M; Zwick EB; Steinwender G; Linhart WE; Schwingenschuh P; Katschnig P; Ott E; Enzinger C
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1880-6. PubMed ID: 19887212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathologic fracture of the tibia associated with Charcot-Marie-Tooth disease].
    Quintart C; Baillon JM; Libotte M
    Acta Orthop Belg; 1999 Mar; 65(1):105-8. PubMed ID: 10217011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling of human walking to optimise the function of ankle-foot orthosis in Guillan-Barré patients with drop foot.
    Jamshidi N; Rostami M; Najarian S; Menhaj MB; Saadatnia M; Firooz S
    Singapore Med J; 2009 Apr; 50(4):412-7. PubMed ID: 19421688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Charcot-Marie-Tooth neural amyotrophy].
    Khurmatulina TI; Obichkina LA; Belogolovykh EN; Baliuk II
    Med Sestra; 1987 May; 46(5):31-4. PubMed ID: 3669966
    [No Abstract]   [Full Text] [Related]  

  • 38. [Charcot Marie Tooth disease: principles of rehabilitation, physiotherapy and occupational therapy].
    Sautreuil P; Delorme D; Baron A; Mane M; Missaoui B; Thoumie P
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():49-54. PubMed ID: 29139387
    [No Abstract]   [Full Text] [Related]  

  • 39. Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol.
    Ferrarin M; Bovi G; Rabuffetti M; Mazzoleni P; Montesano A; Moroni I; Pagliano E; Marchi A; Marchesi C; Beghi E; Pareyson D
    Gait Posture; 2011 May; 34(1):36-43. PubMed ID: 21511477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. About the hypothesis of overwork weakness in Charcot-Marie-Tooth disease.
    Vinci P; Perelli SL; Gargiulo P
    J Rehabil Med; 2009 Sep; 41(9):778; author reply 779. PubMed ID: 19774314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.